Patient Guide: A Phase 2 Study of Ivosidenib in Previously Treated Japanese Subjects With Nonresectable or Metastatic Cholangiocarcinoma With an IDH1 Mutation

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 7 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT06081829
Status: ACTIVE_NOT_RECRUITING
Condition: Cholangiocarcinoma Non-resectable, Cholangiocarcinoma Metastatic
Phase: PHASE2

Find a Study Location Near You

This study is available at 7 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Kashiwa,
  • Kumamoto,
  • Matsuyama,
  • • And 4 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily